BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25359224)

  • 1. Market competition and price of disease management programmes: an observational study.
    van Dijk CE; Venema B; de Jong JD; de Bakker DH
    BMC Health Serv Res; 2014 Oct; 14():510. PubMed ID: 25359224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prices and market power in mental health care: Evidence from a major policy change in the Netherlands.
    Brouns C; Douven R; Kemp R
    Health Econ; 2021 Apr; 30(4):803-819. PubMed ID: 33502788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competition policy for health care provision in the Netherlands.
    Schut FT; Varkevisser M
    Health Policy; 2017 Feb; 121(2):126-133. PubMed ID: 27923494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managed competition in the Netherlands: Do insurers have incentives to steer on quality?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Policy; 2019 Mar; 123(3):293-299. PubMed ID: 30268584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does managed competition constrain hospitals' contract prices? Evidence from the Netherlands.
    Douven R; Burger M; Schut F
    Health Econ Policy Law; 2020 Jul; 15(3):341-354. PubMed ID: 30973119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptance of selective contracting: the role of trust in the health insurer.
    Bes RE; Wendel S; Curfs EC; Groenewegen PP; de Jong JD
    BMC Health Serv Res; 2013 Oct; 13():375. PubMed ID: 24083663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does managed competition affect hospital prices in a social health insurance system? The Colombian case.
    Fernando R; Leticia AB; Antonio J T
    Health Policy Plan; 2018 Nov; 33(9):1037-1046. PubMed ID: 30462221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insurer Market Power Lowers Prices In Numerous Concentrated Provider Markets.
    Scheffler RM; Arnold DR
    Health Aff (Millwood); 2017 Sep; 36(9):1539-1546. PubMed ID: 28874479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation amongst insurers on enhancing quality of care: precondition or substitute for competition?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Econ Policy Law; 2021 Jul; 16(3):273-289. PubMed ID: 32690116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching gains and health plan price elasticities: 20 years of managed competition reforms in The Netherlands.
    Douven R; Katona K; T Schut F; Shestalova V
    Eur J Health Econ; 2017 Nov; 18(8):1047-1064. PubMed ID: 28243775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do Insurers With Greater Market Power Negotiate Consistently Lower Prices for Hospital Care? Evidence From Hospital Price Transparency Data.
    Wang Y; Meiselbach MK; Xu J; Bai G; Anderson G
    Med Care Res Rev; 2024 Feb; 81(1):78-84. PubMed ID: 37594219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician practice competition and prices paid by private insurers for office visits.
    Baker LC; Bundorf MK; Royalty AB; Levin Z
    JAMA; 2014 Oct 22-29; 312(16):1653-62. PubMed ID: 25335147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consumer price sensitivity in Dutch health insurance.
    van Dijk M; Pomp M; Douven R; Laske-Aldershof T; Schut E; de Boer W; de Boo A
    Int J Health Care Finance Econ; 2008 Dec; 8(4):225-44. PubMed ID: 18709549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managed competition and consumer price sensitivity in social health insurance.
    Schut FT; Hassink WH
    J Health Econ; 2002 Nov; 21(6):1009-29. PubMed ID: 12475123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Market Share Matters: Evidence Of Insurer And Provider Bargaining Over Prices.
    Roberts ET; Chernew ME; McWilliams JM
    Health Aff (Millwood); 2017 Jan; 36(1):141-148. PubMed ID: 28069857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Managed competition" for Ireland? The single versus multiple payer debate.
    Mikkers M; Ryan P
    BMC Health Serv Res; 2014 Sep; 14():442. PubMed ID: 25261074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commercial Price Variation for Breast Reconstruction in the Era of Price Transparency.
    Rochlin DH; Rizk NM; Matros E; Wagner TH; Sheckter CC
    JAMA Surg; 2023 Feb; 158(2):152-160. PubMed ID: 36515928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do State Bans of Most-Favored-Nation Contract Clauses Restrain Price Growth? Evidence From Hospital Prices.
    Arnold DR; Gudiksen KL; King JS; Fulton BD; Scheffler RM
    Milbank Q; 2022 Jun; 100(2):589-615. PubMed ID: 35537077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers of access to care in a managed competition model: lessons from Colombia.
    Vargas I; Vázquez ML; Mogollón-Pérez AS; Unger JP
    BMC Health Serv Res; 2010 Oct; 10():297. PubMed ID: 21034481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of market concentration on health care price and quality in hospital markets in Ibadan, Nigeria.
    Awoyemi BO; Olaniyan O
    J Mark Access Health Policy; 2021 Jun; 9(1):1938895. PubMed ID: 34221255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.